Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors
- PMID: 73182
- PMCID: PMC431995
- DOI: 10.1073/pnas.74.10.4605
Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors
Abstract
Serum from mice with growing tumors can prevent ("block") the destruction of tumor cells by immune lymphocytes, as measured in a microcytotoxicity assay. Factors responsible for this blocking activity were purified by binding to immune adsorbents that had been prepared from antibodies obtained by immunizing BALB/c mice to the homologous tumors. Two transplantable BALB/c sarcoma lines with individually different tumor-specific transplantation antigens were studied in parallel. The original tumor-specific blocking activity was recovered by elution of the immune adsorbents; that is, (i) eluates blocked the reduction of surviving tumor cell targets by immune lymphocytes only if the tumor specificity, and (ii) immune adsorbent columns prepared from tumor-immune sera recognized the purified blocking fractions in a tumor-specific fashion, indicating that a portion of the humoral response in the immune mice was directed against a factor that was individually distinct for each tumor. Absorption of eluates with the homologous tumor cells removed their blocking activity, indicating that the blocking factors have antigen-binding properties. Blocking activity in the purified fractions resided in molecules presumptively identified as glycoproteins by affinity chromatography on concanavalin A-Sepharose.
Similar articles
-
Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas.J Immunol. 1976 Nov;117(5 Pt.2):1846-52. J Immunol. 1976. PMID: 62792
-
Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.J Natl Cancer Inst. 1982 Oct;69(4):939-44. J Natl Cancer Inst. 1982. PMID: 6750199
-
Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.J Immunol. 1976 Mar;116(3):724-30. J Immunol. 1976. PMID: 1254951
-
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5. doi: 10.1073/pnas.68.6.1372. Proc Natl Acad Sci U S A. 1971. PMID: 5288389 Free PMC article.
-
Evidence that blocking factors in the sera of multiparous mice are associated with immunoglobulins.Int J Cancer. 1975 Sep 15;16(3):456-64. doi: 10.1002/ijc.2910160313. Int J Cancer. 1975. PMID: 1176203
Cited by
-
Anti-idiotypic antibodies and the induction of specific tumor immunity.Cancer Metastasis Rev. 1987;6(4):489-502. doi: 10.1007/BF00047464. Cancer Metastasis Rev. 1987. PMID: 2450687 Review.
-
Antigen-specific T-cell factors.Immunology. 1980 Dec;41(4):759-87. doi: 10.1007/BF00199524. Immunology. 1980. PMID: 6161877 Free PMC article. Review.
-
Therapeutic vaccination with tumor cells that engage CD137.J Mol Med (Berl). 2003 Feb;81(2):71-86. doi: 10.1007/s00109-002-0413-8. Epub 2003 Feb 8. J Mol Med (Berl). 2003. PMID: 12601523 Review.
-
Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population.Proc Natl Acad Sci U S A. 1978 Jan;75(1):436-40. doi: 10.1073/pnas.75.1.436. Proc Natl Acad Sci U S A. 1978. PMID: 272660 Free PMC article.
-
T-T hybridoma product specifically suppresses tumor immunity.Proc Natl Acad Sci U S A. 1980 May;77(5):2866-70. doi: 10.1073/pnas.77.5.2866. Proc Natl Acad Sci U S A. 1980. PMID: 6446719 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources